Company Filing History:
3 out of 712 
1 out of 1 
1 out of 832,812 Years Active: 1977-1991
Title: Jack Fishman: Innovator in Gastrointestinal Treatments
Introduction
Jack Fishman is a notable inventor based in New York, NY (US), recognized for his contributions to the field of gastrointestinal treatments. He holds a total of 4 patents, showcasing his innovative approach to addressing complex medical issues.
Latest Patents
Among his latest patents, Fishman developed a "Method for controlling gastrointestinal dysmotility in humans by administration of opioid antagonists." This method aims to improve the management of gastrointestinal dysmotility, a condition that affects the movement of the digestive tract. Another significant patent is the "Method of treating patients suffering from chronic pain or chronic cough." This method provides systemic analgesia or a central antitussive effect while avoiding the onset of intestinal hypomotility. It involves the oral administration of dosage units that combine opioid analgesics or antitussives with selected opioid antagonists, which are substantially devoid of systemic antagonist activity when administered orally.
Career Highlights
Throughout his career, Jack Fishman has worked with prestigious institutions, including The Rockefeller University. His work has significantly impacted the medical community, particularly in the treatment of gastrointestinal disorders and pain management.
Collaborations
Fishman has collaborated with esteemed colleagues such as Mary Jeanne Kreek and Shinichi Mayairi, contributing to advancements in medical research and treatment methodologies.
Conclusion
Jack Fishman's innovative work in developing methods for treating gastrointestinal dysmotility and chronic pain has made a lasting impact on the medical field. His patents reflect a commitment to improving patient care and advancing medical science.